Chemoinformaics analysis of N-[2-(4-Hydroxyphenyl)ethyl]benzamide
| Molecular Weight | 241.29 | nRot | 4 |
| Heavy Atom Molecular Weight | 226.17 | nRig | 13 |
| Exact Molecular Weight | 241.11 | nRing | 2 |
| Solubility: LogS | -2.946 | nHRing | 0 |
| Solubility: LogP | 2.338 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 37.7559 |
| nHD | 2 | BPOL | 16.4861 |
| QED | 0.863 |
| Synth | 1.426 |
| Natural Product Likeliness | -0.461 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.317 |
| HIA | 0.034 |
| CACO-2 | -4.638 |
| MDCK | 0.0000135 |
| BBB | 0.345 |
| PPB | 0.938974 |
| VDSS | 0.902 |
| FU | 0.0642001 |
| CYP1A2-inh | 0.948 |
| CYP1A2-sub | 0.1 |
| CYP2c19-inh | 0.916 |
| CYP2c19-sub | 0.1 |
| CYP2c9-inh | 0.811 |
| CYP2c9-sub | 0.88 |
| CYP2d6-inh | 0.873 |
| CYP2d6-sub | 0.774 |
| CYP3a4-inh | 0.237 |
| CYP3a4-sub | 0.264 |
| CL | 11.093 |
| T12 | 0.845 |
| hERG | 0.138 |
| Ames | 0.228 |
| ROA | 0.047 |
| SkinSen | 0.542 |
| Carcinogencity | 0.185 |
| EI | 0.246 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.029 |
| Antiviral | No |
| Prediction | 0.701962 |